US EditionPublished • loading... • Updated
Aurobindo launches Brivaracetam Tablets
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Aurobindo launches Brivaracetam Tablets
EAST WINDSOR, N.J. – Aurobindo Pharma USA, Inc has released Brivaracetam Tablets. Brivaracetam Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.According to IQVIA, U.S. annual sales for Brivaracetam Tablets were approximately $839.7 million for the 12 months ending Dec 2025.💊 Product Details:- Strength: 50 mg & 100 mg📄 Prescribing Information: [Click here]🔗 For more details on Aurobindo’s …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
